Compound Evidence File
#EC-2026-0641
Test Cypionate
Filed under Injectable Oils. The bureau holds 33 laboratory returns for this compound from 12 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
12 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 9.6 | 9.6 | 9.6 | 13 Feb 2025 | 13 Feb 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 9.3 | 8.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 9.2 | 8.2 | 9.7 | 24 May 2026 | 24 May 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 8.6 | 8.6 | 8.6 | 25 Apr 2025 | 25 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.4 | 7.5 | 9.1 | 25 May 2026 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 8.2 | 7.5 | 9.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 8.1 | 7.3 | 9.8 | 24 May 2026 | 24 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 | 21 May 2025 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 1 | 7.8 | 7.8 | 7.8 | 17 Dec 2024 | 17 Dec 2024 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 2.9 | 2.9 | 2.9 | 14 Jan 2025 | 14 Jan 2025 |
Open any subject to view the batch-level evidence for Test Cypionate alone.